TRIM29 Antikörper (N-Term)
Kurzübersicht für TRIM29 Antikörper (N-Term) (ABIN3023984)
Target
Alle TRIM29 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
Klon
-
-
Bindungsspezifität
- N-Term
-
Verwendungszweck
- TRIM29 Antibody (azide and preservative free)
-
Aufreinigung
- Protein G affinity chromatography
-
Immunogen
- An N-terminal human recombinant protein fragment was used as the immunogen for the TRIM29 antibody.
-
Isotyp
- IgG2a, kappa
-
-
-
-
Applikationshinweise
-
Titering of the TRIM29 antibody may be required for optimal performance.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store the TRIM29 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- TRIM29 (Tripartite Motif Containing 29 (TRIM29))
-
Andere Bezeichnung
- TRIM29
-
Hintergrund
- Tripartite motif-containing protein 29 interacts with the intermediate filament protein vimentin, a substrate for the PKC family of protein kinases, and with hPKCI-1, an inhibitor of the PKCs. TRIM29 protein contains both zinc finger and leucine zipper motifs, suggesting that the it may form homodimers and possibly associate with DNA.
-
UniProt
- Q14134
-
Pathways
- p53 Signalweg, Apoptose, DNA Reparatur, Inositol Metabolic Process, Positive Regulation of Response to DNA Damage Stimulus
Target
-